Found: 34
Select item for more details and to access through your institution.
The addition of all-trans retinoic acid to chemotherapy may not improve the outcome of patient with NPM1 mutated acute myeloid leukemia.
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00218
- By:
- Publication type:
- Article
Addition of All-Trans Retinoic Acid to the combination of Fludarabine, Cytarabine, Idarubicin, with or without GCSF in Older Patients with AML Does Not Improve The Outcome in Those with NPM1 Mutations The addition of All-Trans Retinoic Acid to Chemotherpay may not Improve The Outcome of Patient with NPM1 Mutated Acute Myeloid Leukemia
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00218
- By:
- Publication type:
- Article
Large granular lymphocytic leukaemia after solid organ and haematopoietic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 2, p. 318, doi. 10.1111/bjh.16336
- By:
- Publication type:
- Article
Impact of germline CTC1 alterations on telomere length in acquired bone marrow failure.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 5, p. 935, doi. 10.1111/bjh.15862
- By:
- Publication type:
- Article
Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-13001-y
- By:
- Publication type:
- Article
Context dependent effects of ascorbic acid treatment in TET2 mutant myeloid neoplasia.
- Published in:
- Communications Biology, 2020, v. 3, n. 1, p. N.PAG, doi. 10.1038/s42003-020-01220-9
- By:
- Publication type:
- Article
Prognostic implications of chromosome 17 abnormalities in the context of monosomal karyotype in patients with acute myeloid leukemia and complex cytogenetics.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Effect of NPM1 and FLT3 Mutations on the Outcomes of Elderly Patients With Acute Myeloid Leukemia Receiving Standard Chemotherapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 4, p. 435, doi. 10.1016/j.clml.2013.02.021
- By:
- Publication type:
- Article
Treatment of Hairy Cell Leukemia During Pregnancy: Are Purine Analogues and Rituximab Viable Therapeutic Options.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 1, p. 86, doi. 10.1016/j.clml.2012.06.009
- By:
- Publication type:
- Article
Personalized predictions of patient outcomes during and after hospitalization using artificial intelligence.
- Published in:
- NPJ Digital Medicine, 2020, v. 3, n. 1, p. 1, doi. 10.1038/s41746-020-0249-z
- By:
- Publication type:
- Article
Molecular landscape in acute myeloid leukemia: where do we stand in 2016.
- Published in:
- Cancer Biology & Medicine, 2016, v. 13, n. 4, p. 474, doi. 10.20892/j.issn.2095-3941.2016.0061
- By:
- Publication type:
- Article
Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells.
- Published in:
- Nature Communications, 2017, v. 8, n. 4, p. 15102, doi. 10.1038/ncomms15102
- By:
- Publication type:
- Article
TP53 Mutations in Myeloid Neoplasms and Clonal Hematopoiesis of Indeterminate Potential following Cytotoxic Therapy for Antecedent Malignancy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S264, doi. 10.1016/j.clml.2018.07.178
- By:
- Publication type:
- Article
Mutational Landscape of Therapy-Related Myeloid Neoplasms.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S263, doi. 10.1016/j.clml.2018.07.177
- By:
- Publication type:
- Article
Distinct Genomic Associations to Predict Acute Myeloid Leukemia (AML) Progression from Myelodysplastic Syndromes (MDS).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S261, doi. 10.1016/j.clml.2018.07.172
- By:
- Publication type:
- Article
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Whole-genome sequencing identifies novel predictors for hematopoietic cell transplant outcomes for patients with myelodysplastic syndrome: a CIBMTR study.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01431-7
- By:
- Publication type:
- Article
Prognostic landscape of mitochondrial genome in myelodysplastic syndrome after stem-cell transplantation.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Unlocking the Potential of Artificial Intelligence in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
- Published in:
- Current Hematologic Malignancy Reports, 2024, v. 19, n. 1, p. 9, doi. 10.1007/s11899-023-00716-5
- By:
- Publication type:
- Article
Artificial Intelligence in Hematology: Current Challenges and Opportunities.
- Published in:
- Current Hematologic Malignancy Reports, 2020, v. 15, n. 3, p. 203, doi. 10.1007/s11899-020-00575-4
- By:
- Publication type:
- Article
Online and Social Media Resources for Patients with MDS.
- Published in:
- Current Hematologic Malignancy Reports, 2018, v. 13, n. 6, p. 570, doi. 10.1007/s11899-018-0486-2
- By:
- Publication type:
- Article
Making Sense of Prognostic Models in Chronic Myelomonocytic Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2018, v. 13, n. 5, p. 341, doi. 10.1007/s11899-018-0465-7
- By:
- Publication type:
- Article
Molecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDS.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 5, p. 461, doi. 10.1007/s11899-017-0407-9
- By:
- Publication type:
- Article
Improving Prognostic Modeling in Myelodysplastic Syndromes.
- Published in:
- Current Hematologic Malignancy Reports, 2016, v. 11, n. 6, p. 395, doi. 10.1007/s11899-016-0342-1
- By:
- Publication type:
- Article
Prognosis of patients with intermediate risk IPSS‐R myelodysplastic syndrome indicates variable outcomes and need for models beyond IPSS‐R.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 10, p. 1245, doi. 10.1002/ajh.25234
- By:
- Publication type:
- Article
Interactions and relevance of blast percentage and treatment strategy among younger and older patients with acute myeloid leukemia ( AML) and myelodysplastic syndrome ( MDS).
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 2, p. 227, doi. 10.1002/ajh.24252
- By:
- Publication type:
- Article
Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 4, p. 276, doi. 10.1002/ajh.23924
- By:
- Publication type:
- Article
Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 11, p. 961, doi. 10.1002/ajh.23544
- By:
- Publication type:
- Article
The ABNL-MARRO 001 study: a phase 1–2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes.
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10073-w
- By:
- Publication type:
- Article
The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Where to Turn for Second-Line Cytoreduction After Hydroxyurea in Polycythemia Vera?
- Published in:
- Oncologist, 2016, v. 21, n. 4, p. 475, doi. 10.1634/theoncologist.2015-0380
- By:
- Publication type:
- Article
Fibrogenesis in Primary Myelofibrosis: Diagnostic, Clinical, and Therapeutic Implications.
- Published in:
- Oncologist, 2015, v. 20, n. 10, p. 1154, doi. 10.1634/theoncologist.2015-0094
- By:
- Publication type:
- Article
Molecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise?
- Published in:
- Oncologist, 2015, v. 20, n. 9, p. 1069, doi. 10.1634/theoncologist.2015-0067
- By:
- Publication type:
- Article
Advances in Acute Myeloid Leukemia Genomics, Where Do We Stand in 2018?
- Published in:
- Acta Medica Academica, 2019, v. 48, n. 1, p. 35, doi. 10.5644/ama2006-124.240
- By:
- Publication type:
- Article